(Q48194093)

9 February 2018

title

Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. (English)

1 reference

9 February 2018

0 references

1 reference

4

1 reference

9 February 2018

Torsten Wüstenberg

object named as

T Wüstenberg

1

0 references

Hannelore Ehrenreich

object named as

H Ehrenreich

12

0 references

Peter Falkai

object named as

P Falkai

8

0 references

author name string

M Begemann

2

1 reference

9 February 2018

C Bartels

3

1 reference

9 February 2018

S Stawicki

5

1 reference

9 February 2018

D Hinze-Selch

6

1 reference

9 February 2018

A Mohr

7

1 reference

9 February 2018

J B Aldenhoff

9

1 reference

9 February 2018

M Knauth

10

1 reference

9 February 2018

K-A Nave

11

1 reference

9 February 2018

language of work or name

English

0 references

publication date

18 May 2010

1 reference

9 February 2018

published in

Molecular Psychiatry

1 reference

9 February 2018

volume

16

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

26-36, 1

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/mp.2010.51

exact match

0 references

cites work

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Time-lapse mapping of cortical changes in schizophrenia with different treatments

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Another view of therapy for cognition in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Erythropoietin: a candidate compound for neuroprotection in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Emerging biological roles for erythropoietin in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Erythropoietin improves operant conditioning and stability of cognitive performance in mice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Erythropoietin enhances hippocampal long-term potentiation and memory

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Reproducibility of brain tissue volumes in longitudinal studies: effects of changes in signal-to-noise ratio and scanner software

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

A voxel-based morphometric study of ageing in 465 normal adult human brains

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Voxel-based morphometry–the methods

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Decreased entorhinal cortex volumes in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Hippocampal and parahippocampal volumes in schizophrenia: a structural MRI study.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Amygdala volume and verbal memory performance in schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Cerebral cortical gray expansion associated with two second-generation antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Left posterior hippocampal density reduction using VBM and stereological MRI procedures in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Functional asymmetry of superior parietal lobule for working memory in the elderly.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Volumetric abnormalities associated with cognitive deficits in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

FMRI indices of auditory attention in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Fusiform gyrus volume reduction and facial recognition in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Diminished neural sensitivity to irregular facial expression in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Brain structural changes in schizophrenia patients with persistent hallucinations.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Involvement of left inferior frontal gyrus in sentence-level semantic integration

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

The cortical organization of speech processing

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Time course of neural activity correlated with colored-hearing synesthesia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Schizophrenia and the inferior parietal lobule

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Dysfunction of ventral striatal reward prediction in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Antipsychotic drug effects on brain morphology in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

In vivo evidence that erythropoietin protects neurons from ischemic damage

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Evidence for synaptic stripping by cortical microglia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Derivatives of erythropoietin that are tissue protective but not erythropoietic

1 reference

https://api.crossref.org/works/10.1038%2FMP.2010.51

7 January 2021

Identifiers

DOI

10.1038/MP.2010.51

1 reference

9 February 2018

PubMed ID

20479759

1 reference

9 February 2018